An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas

被引:266
作者
Marrugat, J
D'Agostino, R
Sullivan, L
Elosua, R
Wilson, P
Ordovas, J
Solanas, P
Cordón, F
Ramos, R
Sala, J
Masiá, R
Kannel, WB
机构
[1] IMIM, Unitat Lipids & Epidemiol Cardiovasc, E-08003 Barcelona, Spain
[2] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[3] Framingham Heart Dis Epidemiol Study, Boston, MA USA
[4] Boston Univ, Boston, MA 02215 USA
[5] Tufts Univ, Boston, MA 02111 USA
[6] Hosp Girona Josep Trueta, Serv Cardiol & Unitat Coronaria, Girona, Spain
[7] Area Basica Salut Girona 3, Girona, Spain
[8] Unitat Docent Med Familia Girona, Girona, Spain
关键词
D O I
10.1136/jech.57.8.634
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim: To determine whether the Framingham function accurately predicts the 10 year risk of coronary disease and to adapt this predictive method to the characteristics of a Spanish population. Method and Results: A Framingham function for predicting 10 year coronary deaths and non-fatal myocardial infarction was applied to the population of the province of Gerona, Spain, where the cumulated incidence rate of myocardial infarction has been determined since 1988 by a specific registry. The prevalence of cardiovascular risk factors in this region of Spain was established in 1995 by a cross sectional study on a representative sample of 1748 people. The number of cases estimated by the Framingham function for 10 year coronary deaths and non-fatal myocardial infarction was compared with that observed. The Framingham function estimated 2425 coronary heart disease cases in women and 1181 were observed. In men, 9919 were estimated and 3706 were observed. Recalibrating the Framingham equations to the event rate and the prevalence of the risk factors in Gerona led to estimates very close to the number of cases observed in Gerona men and women. Conclusions: The Framingham function estimates more than doubled the actual risk of coronary disease observed in north east Spain. After calibration, the Framingham function became an effective method of estimating the risk in this region with low coronary heart disease incidence.
引用
收藏
页码:634 / 638
页数:5
相关论文
共 25 条
[1]   DIFFERENCES IN CORONARY MORTALITY CAN BE EXPLAINED BY DIFFERENCES IN CHOLESTEROL AND SATURATED FAT INTAKES IN 40 COUNTRIES BUT NOT IN FRANCE AND FINLAND - A PARADOX [J].
ARTAUDWILD, SM ;
CONNOR, SL ;
SEXTON, G ;
CONNOR, WE .
CIRCULATION, 1993, 88 (06) :2771-2779
[2]   Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation [J].
D'Agostino, RB ;
Grundy, S ;
Sullivan, LM ;
Wilson, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :180-187
[3]  
DEARAGON MVM, 1998, B EPIDEMIOLOGICO SEM, V6, P105
[4]   Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project [J].
Dobson, AJ ;
Evans, A ;
Ferrario, M ;
Kuulasmaa, KA ;
Moltchanov, VA ;
Sans, S ;
Tunstall-Pedoe, H ;
Tuomilehto, JO ;
Wedel, H ;
Yarnell, J .
ANNALS OF MEDICINE, 1998, 30 (02) :199-205
[5]   Primary prevention of coronary heart disease: Guidance from Framingham - A statement for healthcare professionals from the AHA task force on risk reduction [J].
Grundy, SM ;
Balady, GJ ;
Criqui, MH ;
Fletcher, G ;
Greenland, P ;
Hiratzka, LF ;
Houston-Miller, N ;
Kris-Etherton, P ;
Krumholz, HM ;
LaRosa, J ;
Ockene, IS ;
Pearson, TA ;
Reed, J ;
Washington, R ;
Smith, SC .
CIRCULATION, 1998, 97 (18) :1876-1887
[6]   SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING FOR PRIMARY PREVENTION OF CORONARY HEART-DISEASE [J].
HAQ, IU ;
JACKSON, PR ;
YEO, WW ;
RAMSAY, LE .
LANCET, 1995, 346 (8988) :1467-1471
[7]   Updated New Zealand cardiovascular disease risk-benefit prediction guide [J].
Jackson, R .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7236) :709-710
[8]  
Kannel W B, 1986, Cardiol Clin, V4, P583
[9]   LONG-TERM EPIDEMIOLOGIC PREDICTION OF CORONARY-DISEASE - THE FRAMINGHAM EXPERIENCE [J].
KANNEL, WB ;
LARSON, M .
CARDIOLOGY, 1993, 82 (2-3) :137-152
[10]  
MARRUGAT J, 1998, CARDIOVASCULAR RISK, V8, P196